共 231 条
[1]
Fealy N(2002)The effect of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration Crit Care Resusc 4 266-270
[2]
Baldwin I(2003)Continuous is not continuous: the incidence and impact of circuit “down-time” on uraemic control during continuous veno-venous haemofiltration Intensive Care Med 29 575-578
[3]
Bellomo R(2012)Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation Intensive Care Med 38 345-358
[4]
Uchino S(1999)The heparin-protamine interaction. A review J Cardiovasc Surg (Torino) 40 659-666
[5]
Fealy N(2009)Heparin-induced thrombocytopenia: a renal perspective Nat Rev Nephrol 5 501-511
[6]
Baldwin I(1983)Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding N Engl J Med 308 258-261
[7]
Morimatsu H(1990)Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients Kidney Int 38 976-981
[8]
Bellomo R(2004)Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study Intensive Care Med 30 260-265
[9]
Antonelli M(2005)Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients Kidney Int 67 2361-2367
[10]
Bonten M(2014)Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the filter life in renal replacement therapy pilot trial Crit Care Resusc 16 131-137